Mirati Therapeutics Inc
NASDAQ:MRTX
Income Statement
Earnings Waterfall
Mirati Therapeutics Inc
Revenue
|
38.2m
USD
|
Cost of Revenue
|
-4.4m
USD
|
Gross Profit
|
33.8m
USD
|
Operating Expenses
|
-798.7m
USD
|
Operating Income
|
-764.9m
USD
|
Other Expenses
|
39m
USD
|
Net Income
|
-725.9m
USD
|
Income Statement
Mirati Therapeutics Inc
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
9
N/A
|
9
N/A
|
9
N/A
|
13
+37%
|
5
-64%
|
5
+12%
|
6
+19%
|
3
-47%
|
2
-29%
|
2
-24%
|
12
+583%
|
13
+10%
|
13
-2%
|
13
N/A
|
74
+460%
|
72
-2%
|
73
+1%
|
78
+7%
|
12
-85%
|
12
+5%
|
19
+52%
|
27
+44%
|
38
+40%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(3)
|
(4)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
12
N/A
|
7
-44%
|
19
+186%
|
34
+77%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(30)
|
(31)
|
(31)
|
(34)
|
(35)
|
(39)
|
(43)
|
(49)
|
(57)
|
(65)
|
(75)
|
(82)
|
(82)
|
(84)
|
(80)
|
(76)
|
(73)
|
(72)
|
(78)
|
(88)
|
(101)
|
(116)
|
(135)
|
(154)
|
(183)
|
(225)
|
(271)
|
(308)
|
(350)
|
(383)
|
(425)
|
(505)
|
(556)
|
(645)
|
(698)
|
(716)
|
(757)
|
(771)
|
(787)
|
(804)
|
(799)
|
|
Selling, General & Administrative |
(11)
|
(11)
|
(11)
|
(12)
|
(12)
|
(13)
|
(14)
|
(15)
|
(16)
|
(16)
|
(16)
|
(16)
|
(15)
|
(15)
|
(15)
|
(15)
|
(14)
|
(13)
|
(15)
|
(16)
|
(18)
|
(22)
|
(26)
|
(31)
|
(37)
|
(43)
|
(51)
|
(61)
|
(70)
|
(83)
|
(94)
|
(104)
|
(118)
|
(137)
|
(162)
|
(187)
|
(213)
|
(240)
|
(259)
|
(281)
|
(292)
|
|
Research & Development |
(19)
|
(20)
|
(19)
|
(22)
|
(23)
|
(26)
|
(29)
|
(33)
|
(41)
|
(49)
|
(59)
|
(66)
|
(67)
|
(68)
|
(65)
|
(61)
|
(59)
|
(58)
|
(63)
|
(72)
|
(82)
|
(94)
|
(108)
|
(123)
|
(147)
|
(183)
|
(220)
|
(247)
|
(280)
|
(299)
|
(332)
|
(401)
|
(437)
|
(509)
|
(536)
|
(529)
|
(544)
|
(532)
|
(527)
|
(523)
|
(507)
|
|
Operating Income |
(30)
N/A
|
(31)
-2%
|
(31)
+1%
|
(34)
-11%
|
(35)
-4%
|
(39)
-10%
|
(43)
-11%
|
(49)
-12%
|
(57)
-17%
|
(65)
-14%
|
(75)
-16%
|
(82)
-9%
|
(82)
-1%
|
(84)
-2%
|
(80)
+5%
|
(76)
+5%
|
(73)
+4%
|
(72)
+2%
|
(69)
+4%
|
(79)
-15%
|
(91)
-16%
|
(103)
-13%
|
(130)
-27%
|
(149)
-15%
|
(177)
-19%
|
(222)
-25%
|
(269)
-21%
|
(306)
-14%
|
(338)
-10%
|
(369)
-9%
|
(412)
-12%
|
(492)
-19%
|
(482)
+2%
|
(573)
-19%
|
(625)
-9%
|
(638)
-2%
|
(745)
-17%
|
(760)
-2%
|
(769)
-1%
|
(779)
-1%
|
(765)
+2%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(17)
|
(20)
|
(30)
|
(30)
|
(8)
|
(5)
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
4
|
2
|
4
|
7
|
9
|
10
|
10
|
8
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
2
|
|
Non-Reccuring Items |
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
2
|
3
|
0
|
4
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
5
|
1
|
2
|
(5)
|
(6)
|
(3)
|
7
|
19
|
33
|
41
|
37
|
|
Pre-Tax Income |
(48)
N/A
|
(53)
-11%
|
(62)
-18%
|
(65)
-5%
|
(45)
+32%
|
(44)
+2%
|
(42)
+4%
|
(46)
-11%
|
(57)
-22%
|
(65)
-14%
|
(75)
-15%
|
(81)
-9%
|
(82)
-1%
|
(83)
-2%
|
(79)
+5%
|
(75)
+5%
|
(72)
+4%
|
(70)
+3%
|
(67)
+4%
|
(77)
-14%
|
(88)
-15%
|
(98)
-12%
|
(125)
-27%
|
(142)
-14%
|
(169)
-19%
|
(213)
-26%
|
(259)
-21%
|
(296)
-14%
|
(329)
-11%
|
(358)
-9%
|
(407)
-14%
|
(491)
-21%
|
(480)
+2%
|
(578)
-21%
|
(631)
-9%
|
(641)
-2%
|
(738)
-15%
|
(740)
0%
|
(737)
+1%
|
(737)
0%
|
(726)
+2%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
0
|
0
|
(0)
|
(1)
|
0
|
0
|
(0)
|
|
Income from Continuing Operations |
(48)
|
(53)
|
(62)
|
(65)
|
(45)
|
(44)
|
(42)
|
(46)
|
(57)
|
(65)
|
(75)
|
(81)
|
(82)
|
(83)
|
(79)
|
(75)
|
(72)
|
(70)
|
(67)
|
(77)
|
(88)
|
(98)
|
(125)
|
(142)
|
(169)
|
(213)
|
(259)
|
(296)
|
(329)
|
(358)
|
(407)
|
(491)
|
(483)
|
(582)
|
(634)
|
(645)
|
(738)
|
(741)
|
(737)
|
(738)
|
(726)
|
|
Net Income (Common) |
(48)
N/A
|
(53)
-10%
|
(62)
-18%
|
(65)
-5%
|
(45)
+32%
|
(44)
+2%
|
(42)
+4%
|
(46)
-11%
|
(57)
-22%
|
(65)
-14%
|
(75)
-15%
|
(81)
-9%
|
(82)
-1%
|
(83)
-2%
|
(79)
+5%
|
(75)
+5%
|
(72)
+4%
|
(70)
+3%
|
(67)
+4%
|
(77)
-14%
|
(88)
-15%
|
(98)
-12%
|
(125)
-27%
|
(142)
-14%
|
(169)
-19%
|
(213)
-26%
|
(259)
-21%
|
(296)
-14%
|
(329)
-11%
|
(358)
-9%
|
(407)
-14%
|
(491)
-21%
|
(483)
+1%
|
(582)
-20%
|
(634)
-9%
|
(645)
-2%
|
(738)
-15%
|
(741)
0%
|
(737)
+1%
|
(738)
0%
|
(726)
+2%
|
|
EPS (Diluted) |
-4.81
N/A
|
-4.78
+1%
|
-4.63
+3%
|
-4.84
-5%
|
-3.29
+32%
|
-3.24
+2%
|
-2.71
+16%
|
-2.85
-5%
|
-3.35
-18%
|
-3.82
-14%
|
-3.84
-1%
|
-4.07
-6%
|
-4.1
-1%
|
-4.2
-2%
|
-3.24
+23%
|
-3.01
+7%
|
-2.89
+4%
|
-2.78
+4%
|
-2.33
+16%
|
-2.58
-11%
|
-2.71
-5%
|
-3.19
-18%
|
-3.56
-12%
|
-3.93
-10%
|
-4.31
-10%
|
-5.69
-32%
|
-6.03
-6%
|
-6.75
-12%
|
-7.38
-9%
|
-7.96
-8%
|
-8.01
-1%
|
-9.53
-19%
|
-9.35
+2%
|
-11.21
-20%
|
-11.43
-2%
|
-11.6
-1%
|
-13.12
-13%
|
-13.18
0%
|
-12.7
+4%
|
-12.66
+0%
|
-11.16
+12%
|